Testing effectiveness (Phase 2)Study completedNCT00758706
What this trial is testing
A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients
Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 55